DaVita Inc.

    Jurisdiction
    United States
    LEI
    M2XHYMU3TZNEZURC6H66
    ISIN
    US23918K1088 (DVA)
    Sectors
    1. Healthcare
    2. Medical - Care Facilities

    Scores

    InsiderPie Expert Score
    58 / 100
    Better than peer group:
    54 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    6 / 7

    Profile

    DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. Read full profile

    Fundamentals

    Net revenue
    €11.23B
    Gross margin
    31.2%
    EBIT
    €1.77B
    EBIT margin
    15.7%
    Net income
    €713.30M
    Net margin
    6.4%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Congress transactions

    Name Transaction date Value
    Julie Johnson October 7, 2025 $1.00K–$15.00K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Warren Buffett 35M $5.38B -953K Sell
    Ray Dalio 228K $34.92M -12K Sell

    Earnings Calls

    Latest earnings call: August 5, 2025 (Q2 2025)

    Add to watchlist

    Notifications